Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omeprazole for GERD in Systemic Sclerosis
NCT03561233Phase 1Completed
- Sponsor
- Khon Kaen University
- Start
- May 2013
- Primary completion
- May 2018
- Modality
- Small Molecules
01
Overview
Phase 1, open-label trial of omeprazole in gastroesophageal reflux disease (GERD), sponsored by Khon Kaen University. Primary endpoints: Visual Analogue Scale for Heartburn Severity at 4 weeks and Frequency Scale for the Symptoms of GERD at 4 weeks. Started May 2013; status: completed.
02
Drugs
omeprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT03561233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03561233.